Cargando…

Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment

Detalles Bibliográficos
Autores principales:	Serpa, Jacinta, Torre, Cheila, Caiado, Francisco, Dias, Sérgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255031/

Ejemplares similares

Breast tumors induce the recruitment of AC133(+)KDR(+ )endothelial precursor cells mobilized by plasma vascular endothelial growth factor
por: Botelho, M, et al.
Publicado: (2005)

DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)
por: Quentmeier, Hilmar, et al.
Publicado: (2012)

Endothelial progenitor cells and integrins: adhesive needs
por: Caiado, Francisco, et al.
Publicado: (2012)

The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral Revascularization
por: Park, Young Seok, et al.
Publicado: (2012)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
por: Huh, J, et al.
Publicado: (2012)

Serum and molecular assessment of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α) in canine mammary tumors
por: Moschetta, Marina G, et al.
Publicado: (2013)

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

Cell death induced by HDACS inhibitors in ovarian cancer cell lines (serous and clear cells carcinomas) – role of NOTCH, TP53 and FN1
por: Silva, Fernanda, et al.
Publicado: (2010)

Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells
por: Chou, Mary T, et al.
Publicado: (2002)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

IL-15 is an inflammatory mediator in the tumor microenvironment
por: Anthony, Scott M, et al.
Publicado: (2015)

Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot
por: Škorić-Milosavljević, Doris, et al.
Publicado: (2021)

Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses
por: Srivastava, Minu, et al.
Publicado: (2015)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels
por: Cariboni, Anna, et al.
Publicado: (2011)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

Correction to: Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot
por: Škorić-Milosavljević, Doris, et al.
Publicado: (2021)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
por: Kosmides, Alyssa K, et al.
Publicado: (2014)

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
por: Wu, Tc, et al.
Publicado: (2013)

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
por: Pedersen, Sara R, et al.
Publicado: (2015)

Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013)

Trp53 inactivation in the tumor microenvironment promotes tumor progression by enhancing pro-inflammatory tumor stromal populations
por: Guo, Gang, et al.
Publicado: (2013)

PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment
por: Li, Jing, et al.
Publicado: (2014)

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment
por: Mollick, J, et al.
Publicado: (2013)

Differential outcomes of 609 rapid drug desensitization (RDD) for type I hypersensitivity to platins and taxanes
por: Caiado, Joana, et al.
Publicado: (2014)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

Regulation of endothelial function by coagulation proteases in sepsis
por: McLaughlin, JN, et al.
Publicado: (2011)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Desensitization induces hyporesponsiveness and cell-surface phenotype changes on mouse mast cells
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2014)

Bone Marrow-Derived Endothelial Progenitors Expressing Delta-Like 4 (Dll4) Regulate Tumor Angiogenesis
por: Real, Carla, et al.
Publicado: (2011)

Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
por: Elias, Ana Paula, et al.
Publicado: (2008)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Basophil activation test in allergic patients to platins undergoing rapid desensitization
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2014)

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
por: Speirs, V, et al.
Publicado: (1999)

Identification of novel immune regulators of tumor growth using RIPPS screening in vivo
por: Brennan, Tom, et al.
Publicado: (2015)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b3gqhl7aq9vq6jejuhtn5u17nf